1. Introduction {#sec1}
===============

Wnt signaling controls important aspects of animals development, and its deregulation has been casually linked to cancer [@bib1]. Aberrant regulation of the Wnt signaling pathway is a prevalent theme in cancer biology [@bib2]. A key effector of the canonical Wnt pathway is β-catenin, or Armadillo in Drosophila, a highly unstable cytoplasmic protein that is constitutively phosphorylated and targeted for proteasomal degradation [@bib3]. Once established, β-catenin accumulates in the nucleus and associates with DNA-bound TCF/LEF factors, thus providing a platform for the recruitment of various general transcriptional co-activators to Wnt target genes, including chromatin modifiers and remodeling factors [@bib4].

Pygopus (Pygo), a new component of Wnt signaling pathway, contains a single zinc-coordinated PHD finger in its C-terminus, by which it binds directly to a short Lgs domain (called homology domain 1 (HD1)); Lgs in turn uses its homology domain 2 to bind to Armadillo, thus forming a "chain-of-adaptors" [@bib5], [@bib6].

The Zn-coordinated PHD fingers of Pygopus proteins are critical for β-catenin-dependent transcriptional switches in normal and malignant tissues [@bib4]. Pygo and Lgs interact with β-catenin during the formation of the canonical transcriptional complex and are required for accumulation of β-catenin in the nucleus [@bib8]. Additionally, a putative nuclear localization signal (NLS) was identified within the N-terminal domain of Pygo, suggesting a possible role of nuclear importation of β-catenin [@bib9], [@bib10].

Pygo has also been implicated in Wnt-independent roles both in cancer [@bib11] and in development [@bib12], [@bib13]. Human genome carries two orthologs of Drosophila Pygo, *Pygo1* and *Pygo2*[@bib14]. Previous studies have provided evidence that the human Pygo is expressed in the majority of breast and epithelial ovarian primary carcinomas [@bib15]. Additionally, *Pygo2* was highly expressed in glioma tissues and required for the growth of glioblastoma cells [@bib16].

In the present study, we investigated the potential effects of *Pygo2* on the growth of renal cell carcinoma (RCC) cells *in vivo* and *in vitro*. However, little or no information is currently available about the invasiveness of renal malignant tumors by which Pygo 2 proteins increased, and the expression of its related proteins (matrix metalloproteinase-7 (MMP-7), matrix metalloproteinase-9 (MMP-9), vascular endothelial growth factor (VEGF)) is still unknown. We also explore VEGF expression level in nude mice which involved by pygo2 how to exert its effects.

2. Materials and methods {#sec2}
========================

2.1. Cell culture {#sec2.1}
-----------------

The human RCC cell lines, OS-RC-2, was purchased from the Cell Center of Chinese Academy of Sciences and maintained in RPMI-1640 supplemented with 10% fetal bovine serum (FBS) (Invitrogen Corp, USA) and at 37°C in a humidiﬁed atmosphere containing 95% air and 5% CO~2~. Cells were trypsinized upon confluency and propagated twice before being subcultured into 6- or 96-well plates for further experiments.

2.2. Lentivirus packaging, cell infection, and generation of stable cell lines {#sec2.2}
------------------------------------------------------------------------------

To determine the role of *Pygo2* gene in the growth of OS-RC-2 cells, we used a lentivirus vector to mediate Pygo2 overexpression or silencing according to the manufacturer\'s instructions. Briefly, 293FT cells were co-transfected with the constructs containing Pbobi-HA-Pygo2-full-IRES-Puro, Pbobi-GFP, Pll3.7-neo-Pygo2 (Pygo2-shRNA), or Pll3.7-control (Pygo2-scrRNA), and packaging mixture. The viral supernatant was harvested after 48--72 h and titers of the resulted virus were determined by infecting 293T cells with serial dilutions of concentrated lentivirus. After 48 h of incubation, the cells were analyzed by Western blotting to determine silent efficiency or overexpression of the *Pygo2* gene. For the generation of stable cell lines, OS-RC-2 cells were infected with viral supernatant plus 2000× polybrene (Sigma, San Francisco, USA) for 24 h. After antibiotic selection for 2 weeks, stable clones were obtained.

2.3. Western blot analysis {#sec2.3}
--------------------------

At 48 h after infection, cells were washed twice with cold Phosphate buffer saline (PBS), then harvested using cell scrapers. By centrifuging (3000 rpm, 4 min), cell debris were removed. Total protein was extracted using a protein extraction solution containing lysis buffer, 100× Phenylmethanesulfonyl fluoride (PMSF), and 100× protease inhibitor cocktail. Proteins (80 μg) were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and electrotransferred to nitrocellulose membranes (Amersham Pharmacia Biotech, Montreal, Canada). Rabbit polyclonal antibodies against human Pygo2 were presented from Xiamen University, College of Life Science, China.

2.4. Cell proliferation assay {#sec2.4}
-----------------------------

At 48 h after infection, cells were seeded at 5 × 10^3^ cells per well in 96-well plates and incubated in medium containing 10% FBS and allowed to attach for 24 h. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) was added to each well and incubated for 4 h at 37°C. Finally, the medium was discarded carefully, and 150 μL dimethylsulfoxide (DMSO) was added to each well to dissolve MTT. Absorbance at 590 nm with reference filter of 620 nm was measured using a spectrophotometer. The experiment was independently repeated three times.

2.5. Cell invasion assay {#sec2.5}
------------------------

At 48 h after infection, The cell was diverted and maintained in dulbecco\'s modified eagle medium (DMEM) with no FBS and cultured at 37°C for 24 h. Five hundred microlitre DMEM with no FBS was added into the wells of a Tanswell and cultured at 37°C for 1 h. Tanswell were diverted to 24-well plates and added to 200 μL cell suspension (1.5 × 10^5^/mL) in upper well and 200 μL DMEM in lower well. After cultured in a 37°C for 24 h, Tanswells were washed thrice with PBS, fixed in 4% paraformaldehyde (PFA) for 30 min, stained with 0.1% viola crystalline for 20 min. Photographs were taken at a magnification of 200×. The number of invading cells was quantified by counting the stained cells in randomly selected fields of the membrane. All experiments were repeated there times.

2.6. Colony formation assay {#sec2.6}
---------------------------

At 48 h after infection, 1000 cells per well were seeded in 6-well plates and cultured. After 12 days, the plates were stained with Giemsa (0.4 g Giemsa, 25 mL methanol, 25 mL glycerol), followed by washing with water to remove excess dye. Colonies were quantified by counting. Each experiment was repeated in triplicates. The results are presented as the average of three independent experiments.

2.7. *In vivo* tumor formation {#sec2.7}
------------------------------

OS-RC-2 cells were harvested with trypsin-EDTA, washed and resuspended in PBS. Nude mice (female 3--4 weeks old) were injected in the axillary subcutaneous with 4 × 10^6^ OS-RC-2 cells. Tumor sizes were measured using a caliper when tumor nodules were visible. The animals were maintained in laminar flow cabinets under specific pathogen-free conditions. The 16 xenograft model mice were randomly divided into four groups: Pygo2shRNA group, Pygo2scrRNA group, Pygo2-overexpression (Pygo2OE) group, and green fluorescent protein (GFP) group. The size of the tumors was measured every 3 days after inoculation. Tumor volume was calculated using the formula: L × S^2^/2, where L is the longest tumor diameter and S is the shortest tumor diameter. The tumor-bearing mice were sacrificed 4 weeks after inoculation and the tumors were incised and weighed. The tumors were fixed in 10% formalin solution for immunohistochemistry staining.

2.8. Histological analysis {#sec2.8}
--------------------------

Formalin-fixed tissue samples were embedded in paraffin and sectioned. The resulted sections were stained with Hematoxylin and Eeosin (H&E).

2.9. Immunohistochemistry {#sec2.9}
-------------------------

Sections were subject to the Super Vision (SV) method using the following primary monoclonal rabbit anti-human anti-bodies: Pygo2 (1: 200, obtained from Xiamen University, College of Life Science, China), MMP-7 (1: 100), MMP-9 (1: 100), VEGF (1:100) (Pierce, NJ, USA). These antibodies were incubated overnight at 4 °C, the reactions were amplified with peroxidase-labeled secondary antibody and visualized with DAB (3, 3′ N-Diaminobenzidine Tertrahydrochloride) (Maixin Biotechnology, Fuzhou, China). Hematoxylin was used to counterstain.

2.10. Statistical methods {#sec2.10}
-------------------------

Statistical analyses of the data were performed using the SPSS (version 13.0) statistical software (IBM, NY, USA). One-Way ANOVA analyses followed by Fisher\'s Exact Test were performed to compare differences among treatment groups. *p* value \< 0.05 was considered statistically significant.

3. Results {#sec3}
==========

3.1. Knockdown and overexpression of Pygo2 in OS-RC-2 cells {#sec3.1}
-----------------------------------------------------------

To study the function of Pygo2 in OS-RC-2 cells, we used lentivirus vector mediated Pygo2 knockdown (Pygo2shRNA) and overexpression (Pygo2OE). Lentivirus was packaged and used to infect OS-RC-2 cells. Lentivirus expressing a scrambled shRNA (Pygo2scrRNA) was used as a control for Pygo2shRNA, and GFP as a control for Pygo2OE. The lentivirus infection rate was quite high as measured by the percent of cells expressing GFP fluorescence 48 h following infection ([Fig. 1](#fig1){ref-type="fig"}A). To determine the expression of Pygo2 in the infected cells, we performed Western blotting assay. As shown in [Fig. 1](#fig1){ref-type="fig"}B, Pygo2 protein was successfully knocked down by its shRNA (comparing Pygo2shRNA to PygoscrRNA). Overexpression of Pygo2 protein was also successfully achieved in OS-RC-2 cells by Pygo2OE ([Fig. 1](#fig1){ref-type="fig"}B).Figure 1Knockdown and overexpression of Pygo2 by Pygo2shRNA and an overexpressing vector respectively. (A) OS-RC-2 cells were infected with the indicated lentivirus including Pygo2-targeting shRNA (Pygo2shRNA), control shRNA (Pygo2scrRNA), Pygo2-overexpression (Pygo2OE), and GFP control. Bright field and fluorescence cell images were taken 2 days following transduction (100× magnification). (B) Protein extracted from the cells transduced as in (A) was subject to Western blotting assay. Protein levels of Pygo2 were detected by using an anti-Pygo2 antibody, and β-actin was detected to serve as a control for protein loading.

3.2. Effect of Pygo2 on cell proliferation *in vitro* {#sec3.2}
-----------------------------------------------------

To determine the effect of Pygo2 knockdown on OS-RC-2 proliferation, we first determined cell proliferation by MTT assay. Forty-eight hours after virus infection, cells infected with Pygo2shRNA showed significantly slower growth compared those infected with Pygo2OE, Pygo2scrRNA and GFP ([Fig. 2](#fig2){ref-type="fig"}A).Figure 2Effect of Pygo2 on OS-RC-2 cells growth *in vitro*. (A) Growth rates of OS-RC-2 cells as determined by MTT assay. (B) The effects of the Pygo2shRNA and overexpression of Pygo2 on colony formation of OS-RC-2 cells: a, Pygo2scrRNA; b, Pygo2shRNA; c, GFP; and d, Pygo2OE. (C) Invasion assay using BD BioCoat Matrigel Invasion Chambers. The stained cells were invasive cells in the lower chamber (200× magnification). (D) The number of migrating cells in (C) was quantified by photography. A 6-fold increase in the number of migrating cells in Pygo2OE was noted compared to Pygo2 knockdown in OS-RC-2 cell lines (*p* \< 0.001).

We next investigated the effects of the Pygo2shRNA and overexpression of Pygo2 on cell colony formation of the RCC cells. Our results showed that Pygo2shRNA apparently prevented colony formation of RCC cells. Compared with other treatments, cells infected with Pygo2shRNA exhibited significantly less colonies ([Fig. 2](#fig2){ref-type="fig"}B).

3.3. Effect of Pygo2 on tumor cell invasion {#sec3.3}
-------------------------------------------

To investigate the role of Pygo2 in tumor invasion, we performed matrigel migration assay. Suppression of Pygo2 by its shRNA significantly decreased the invasion ability of OS-RC-2 cell, whereas overexpression of Pygo2 increased cell invasion ([Fig. 2](#fig2){ref-type="fig"}C and D). This result thus suggests that *Pygo2* gene has a role in promoting cells invasion in OS-RC-2 cells.

3.4. Effect of Pygo2 on tumor growth in a nude mice xenograft model {#sec3.4}
-------------------------------------------------------------------

To further investigate the role of Pygo2 in RCC *in vivo*, we established xenografts by subcutaneous injection of 4 × 10^6^ OS-RC-2 cells including Pygo2shRNA, Pygo2scrRNA, GFP and Pygo2OE. As shown in [Fig. 3](#fig3){ref-type="fig"}A and B, Pygo2shRNA strikingly decreased the growth of OS-RC-2 cells xenografts in nude mice, whereas in mice treated with overexpression of Pygo2 tumors grew promptly on the third day, the other animals had large tumors after 1. Notably, in Pygo2shRNA group, tumor growth was delayed compared to the other three groups. After 4 weeks, we observed that the volume of tumor derived from Pygo2 knockdown cells was significantly smaller than that derived from control cells ([Fig. 3](#fig3){ref-type="fig"}B). When the nude mice were dissected, we found the lung surface in mice treated with Pygo2 overexpression has scattered nodules. As shown in [Fig. 3](#fig3){ref-type="fig"}C, H&E staining confirmed that scattered nodules were metastatic tumors. These results indicated that Pygo2 can participate in the regulation of cell migration and invasion.Figure 3The effect of Pygo2 knockdown and overexpression on tumor growth. (A) Nude mice inoculated with Pygo2shRNA, Pygo2scrRNA, GFP and Pygo2OE cells were sacrificed 5 weeks after inoculation. Note one mouse inoculated with Pygo2shRNA did not form tumor. (B) Tumor growth curves. Average volume of tumors in each group is plotted at different time points (*p* \< 0.05). (C) Lung metastatic tumor was observed by light microscopy (Hematoxylin and Eeosin (H&E) staining, 200× magnification). (a) Pygo2shRNA group showing the effect of Pygo2 suppression on OS-RC-2 cells exhibit no lung metastatic tumor; (b) Control group; (c) Pygo2OE group showing the overexpression effect of Pygo2 on OS-RC-2 cells exhibit lung metastatic tumor (as shown by the arrow); (d) GFP group.

3.5. The expression of MMP-7, MMP-9, VEGF, as determined by immunohistochemistry {#sec3.5}
--------------------------------------------------------------------------------

To examine whether Pygo2 expression *in vivo* was associated with invasion and angiogenesis, we detected the expression of MMP-7, MMP-9 and VEGF in tumor tissue. As shown in [Fig. 4](#fig4){ref-type="fig"}A, we verified the expression of Pygo2 in tumor tissue by immunohistochemistry (IHC). We noticed that in Pygo2 knockdown tumors, no signals seemed to diffuse in the cytoplasm of cancer cells, the other three groups were prominently augmented, especially in tumor tissue treated with overexpression of Pygo2. However, as shown in [Fig. 4](#fig4){ref-type="fig"}A, Pygo2 depletion could not obviously reduce the expression of MMP-9, suggesting that Pygo2 protein may not affect MMP-9 by regulating the levels of β-catenin.Figure 4Immunohistochemical staining for Pygo2, MMP-9, MMP-7 and VEGF in tumor tissue. (A) Representative images of immunohistochemical staining of Pygo2, MMP-9, MMP-7 and VEGF expression (400× magnification). (B) Quantification of MMP-9-expressing cells (% of positive cells). The staining index was decreased in Pygo2shRNA-treated tumor tissues compared with that in control groups (\*\**p* \< 0.01). (C) Statistical summary of MMP-7 positive cells, Pygo2shRNA protein expression was at a much lower percentage, a significant dose-dependent reduction in tumor tissues compared with control tumor tissues (\*\*\**p* \< 0.001). (D) The rate of VEGF expression in Pygo2OE group is higher than that in Pygo2shRNA group (\*\*\**p* \< 0.001).

We then explored the cause--effect relationship between the expression of Pygo2 and VEGF, and found that VEGF expression was strongly upregulated in a background of Pygo2 deficiency ([Fig. 4](#fig4){ref-type="fig"}). Taken together, these results suggest that Pygo2 may be involved in RCC progression by regulating cell invasion and angiogenesis.

4. Discussion {#sec4}
=============

To date, RCC, the most common form of adult neoplastic renal disease, has only been marginally investigated for aberrations in the Wnt/beta-catenin signaling pathway [@bib17]. Pygo2 is an important component of Wnt/β-catenin transcriptional complex [@bib18]. Pygo and Lgs interact with β-catenin during the formation of the canonical transcriptional complex and are required for accumulation of β-catenin in the nucleus [@bib19]. In this study, we demonstrated that Pygo2 knockdown inhibited cell proliferation, colony formation and cell invasion by *in vitro* assays. Notably, Pygo2 is overexpressed and required in OS-RC-2 cell lines. Therefore, Pygo2 may serve a prognostic molecular marker in association with RCC.

We further demonstrated that Pygo2 participated in the regulation of angiogenesis and invasive ability of OS-RC-2 cells by *in vivo* assays. Our results indicated that Pygo2 knockdown effectively induced growth inhibition of OS-RC-2 cell lines. However, overexpression of Pygo2 did not significantly increase tumor size and weight. This result may be explained that the overexpression of Pygo2 cannot stimulate the expression of β-catenin. In addition, Schwab et al. [@bib14] reported that the proteins encoded by mammalian *Pygopus* genes were often mere modulators of canonical Wnt signaling intensity, and not essential components. The important finding from our study was the effect of Pygo2OE on pulmonary metastasis in a nude mice model, suggesting its potential involvement in regulating cell migration and invasion.

Angiogenesis is a key process in the growth and metastasis of solid tumors [@bib8]. VEGF regulates endothelial cell proliferation and the formation of blood vessels, in addition to promoting angiogenesis. Matrix metalloproteinases (MMPs), a large group of secreted proteinases that require divalent cations for their catalytic activities, play important roles in a variety of physiological and pathological processes such as tumor invasion, as well as distant metastasis [@bib7]. In the present study, we have shown that down-regulated Pygo2 is associated with decreased expression of MMP-7 and VEGF. Barnes [@bib20] found that expression of β-catenin enhanced expression of MMP-7 protein, suggesting that expression of Pygo2 could activate Wnt signal transduction pathway leading to the expression of MMP-7. Interestingly, we noted, however, that tumor invasion was not completely eliminated by suppressing the expression of Pygo2 protein. We found that the lack of Pygo2 could not obviously reduce the expression of MMP-9, suggesting Pygo2 accumulation in tumor tissues may not activate the expression of MMP-9 by the canonical Wnt pathway.

In summary, we demonstrate that a reduced expression of Pygo2 inhibits RCC growth *in vitro* and *in vivo*. Additionally, Pygo2 is involved tumor invasion, metastasis and blood-vessel growth (high expression of VEGF), implying that Pygo2 may have a key function in the carcinogenesis of RCC. Thus, we speculate its requirement for growth in RCC, which definitely needs further experiment data to support the hypothesis.
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